B, E., CU, N., AP, K., M, F., J, v. T., C, Z., . . . M, H. (2023). First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia. The New England journal of medicine, 388(19), 1739. https://doi.org/10.1056/NEJMoa2213093
Chicago Style (17th ed.) CitationB, Eichhorst, et al. "First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia." The New England Journal of Medicine 388, no. 19 (2023): 1739. https://doi.org/10.1056/NEJMoa2213093.
MLA (9th ed.) CitationB, Eichhorst, et al. "First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia." The New England Journal of Medicine, vol. 388, no. 19, 2023, p. 1739, https://doi.org/10.1056/NEJMoa2213093.
Warning: These citations may not always be 100% accurate.